Cargando…
Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy
Tumor-specific T cells (TSTs) are essential components for the success of personalized tumor-infiltrating lymphocyte (TIL)-based adoptive cellular therapy (ACT). Therefore, the selection of a common biomarker for screening TSTs in different tumor types, followed by ex vivo expansion to clinical numb...
Autores principales: | Ge, Wu, Dong, Yuqian, Deng, Yao, Chen, Lujuan, Chen, Juan, Liu, Muqi, Wu, Jianmin, Wang, Wei, Ma, Xiaoqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702804/ https://www.ncbi.nlm.nih.gov/pubmed/36451828 http://dx.doi.org/10.3389/fimmu.2022.1003626 |
Ejemplares similares
-
The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors
por: Le, Thanh-Phuong, et al.
Publicado: (2017) -
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
por: Etxebeste-Mitxeltorena, Mikel, et al.
Publicado: (2021) -
Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
por: Lloyd, Angharad, et al.
Publicado: (2013) -
Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy
por: Zoine, Jaquelyn T., et al.
Publicado: (2022) -
Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis
por: Hu, Congqi, et al.
Publicado: (2022)